| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RENB | Common Stock | Other | +17.5 M | 17.5 M | Feb 16, 2018 | Direct | F1 | |||
| transaction | RENB | Common Stock | Other | +1.27 M | +7.23% | 18.8 M | Dec 31, 2018 | Direct | F2 | ||
| transaction | RENB | Common Stock | Other | +3.63 M | +19.3% | 22.4 M | Jul 30, 2019 | Direct | F2 | ||
| transaction | RENB | Common Stock | Other | -17.5 M | -78.17% | 4.9 M | May 29, 2020 | Direct | F3 | ||
| transaction | RENB | Common Stock | Other | +61.2 K | +1.25% | 4.96 M | Dec 14, 2020 | Direct | F2 | ||
| transaction | RENB | Common Stock | Other | +97 K | +1.96% | 5.06 M | Apr 11, 2022 | Direct | F2 | ||
| transaction | RENB | Common Stock | Other | -4.96 M | -98.08% | 97 K | Apr 15, 2022 | Direct | F3 | ||
| transaction | RENB | Common Stock | Other | +1.22 M | +1253.68% | 1.31 M | Oct 13, 2022 | Direct | F2 |
Weird Science LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
| Id | Content |
|---|---|
| F1 | The Reporting Person received these shares as merger consideration in exchange for the Reporting Person's common stock of Enochian BioPharma, Inc., which the Issuer acquired by merger on February 16, 2018. In addition to such shares, the Agreement and Plan of Merger governing the merger (the "Merger Agreement") provides that upon the exercise or conversion of options and warrants to purchase shares of the Issuer's common stock that were outstanding as of the closing of the merger, the Issuer will issue a like number of shares of Common Stock (referred to as "Earn-Out Stock") to the former stockholders of Enochian BioPharma, Inc., including the Reporting Person, on a pro rata basis. The Reporting Person's right to receive additional shares of the Issuer's common stock as Earn-Out Stock became fixed and irrevocable on February 16, 2018, the closing date of the merger. |
| F2 | Shares were received by the Reporting Person as Earnout Stock pursuant to the Merger Agreement. The Reporting Person's right to the Earnout Stock became fixed and irrevocable on February 16, 2018, the date of the closing under the Merger Agreement. |
| F3 | Pro rata distribution to the members of the Reporting Person. |